Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

APOBEC3G anticorps (C-Term)

APOBEC3G Reactivité: Humain WB Hôte: Chèvre Polyclonal unconjugated
N° du produit ABIN374818
  • Antigène Voir toutes APOBEC3G Anticorps
    APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
    Épitope
    • 15
    • 9
    • 9
    • 8
    • 8
    • 7
    • 6
    • 5
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 79
    • 3
    • 2
    • 1
    Humain
    Hôte
    • 73
    • 5
    • 1
    Chèvre
    Clonalité
    • 77
    • 2
    Polyclonal
    Conjugué
    • 36
    • 8
    • 7
    • 7
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp APOBEC3G est non-conjugé
    Application
    • 73
    • 43
    • 28
    • 13
    • 13
    • 13
    • 6
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
    Specificité
    This antibody reacts to APOBEC3G.
    Purification
    Affinity chromatography
    Immunogène
    Peptide with sequence C-DEHSQDLSGRLR, from the C Terminus of the protein sequence
    Top Product
    Discover our top product APOBEC3G Anticorps primaire
  • Indications d'application
    Peptide ELISA: 1/16000. Western Blot: 0.5 - 1.5 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    0,5 mg/mL
    Buffer
    Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
    Autre désignation
    APOBEC3G (APOBEC3G Produits)
    Synonymes
    anticorps A3G, anticorps ARCD, anticorps ARP-9, anticorps ARP9, anticorps CEM-15, anticorps CEM15, anticorps bK150C2.7, anticorps dJ494G10.1, anticorps apolipoprotein B mRNA editing enzyme catalytic subunit 3G, anticorps APOBEC3G
    Sujet
    APOBEC3G is a DNA deaminase (cytidine deaminase) that mediates a form of innate resistance to retroviral infections (at least to HIV1 infection) by triggering G-to-A hypermutation in the newly synthetized viral DNA. The replacements C-to-U in the minus strand DNA of HIV1 during reverse transcription, leads to G-to-A transitions in the plus strand. The inhibition of viral replication is either due to the degradation of the minus strand before its integration or to the lethality of the hypermutations. Modification of both DNA strands is not excluded. This antiviral activity is neutralized by the virion infectivity factor (VIF), that prevents the incorporation of APOBEC3G into progeny HIV1 virions by both inhibiting its translation and/or by inducing its ubiquitination and subsequent degradation by the 26S proteasome. APOBEC3G binds a variety of RNAs, but does not display detectable APOB, NF1 and NAT1 mRNA editing. APOBEC3G is involved in hepatitis B virus (HBV) resistance probably primarily by inhibiting viral pregenomic RNA packaging. This activity is independent of the cytidine deaminase activity, as the inactivated protein is able to inhibit HBV replication. During HBV infection, APOBEC3G does not seem to be involved in the editing of HBV DNA, but this might occur in particular cellular contexts or with specific viral strains. APOBEC3G is a homodimer. It interacts with APOBEC3B, APOBEC3F and HIV1 VIF in a species specific manner. It is expressed in spleen, testes, ovary and peripheral blood leukocytes and CD4+ lymphocytes. Also expressed in non permissive peripheral blood mononuclear cells, and several tumor cell lines, no expression detected in permissive lymphoid and non-lymphoid cell lines. Normally not expressed in the liver, but it is possible that it is induced in the course of HBV infection, for instance under the influence of cytokines. APOBEC3G is ubiquitinated in the presence of HIV1 VIF. Association with VIF targets the protein for proteolysis by the ubiquitin dependent proteasome pathway. APOBEC3G inhibits also the infectivity of retroviral particles only distantly related to HIV1, such as the simian immunodeficiency virus (SIV), the equine infectious anemia virus (EIAV) and the murine leukemia virus (MLV).Synonyms: APOBEC-3G, APOBEC-related cytidine deaminase, ARCD, ARP9, CEM15, DNA dC->dU-editing enzyme APOBEC-3G, MDS019
    ID gène
    60489, 9606
    UniProt
    Q9HC16
Vous êtes ici:
Support technique